Abstract

Constipation and defecatory dysfunctions are frequent symptoms in patients with Parkinson’s disease (PD). The pathology of Lewy bodies in colonic and rectal cholinergic neurons suggests that cholinergic pathways are involved in colorectal dysmotility in PD. However, the underlying mechanism is unclear. The aim of the present study is to examine the effect of central dopaminergic denervation in rats, induced by injection 6-hydroxydopamine into the bilateral substania nigra (6-OHDA rats), on colorectal contractive activity, content of acetylcholine (ACh), vasoactive intestinal peptide (VIP) and expression of neural nitric oxide synthase (nNOS) and muscarinic receptor (MR). Strain gauge force transducers combined with electrical field stimulation (EFS), gut transit time, immunohistochemistry, ELISA, western blot and ultraperformance liquid chromatography tandem mass spectrometry were used in this study. The 6-OHDA rats exhibited outlet obstruction constipation characterized by prolonged transit time, enhanced contractive tension and fecal retention in colorectum. Pretreatment with tetrodotoxin significantly increased the colorectal motility. EFS-induced cholinergic contractions were diminished in the colorectum. Bethanechol chloride promoted colorectal motility in a dose-dependent manner, and much stronger reactivity of bethanechol chloride was observed in 6-OHDA rats. The ACh, VIP and protein expression of nNOS was decreased, but M2R and M3R were notably upregulated in colorectal muscularis externa. Moreover, the number of cholinergic neurons was reduced in sacral parasympathetic nucleus (SPN) of 6-OHDA rats. In conclusion, central nigrostriatal dopaminergic denervation is associated with decreased cholinergic neurons in SPN, decreased ACh, VIP content, and nNOS expression and upregulated M2R and M3R in colorectum, resulting in colorectal dysmotility, which contributes to outlet obstruction constipation. The study provides new insights into the mechanism of constipation and potential therapeutic targets for constipation in PD patients.

Highlights

  • Gastrointestinal (GI) symptoms, especially constipation and defecatory dysfunctions, are very common in the preclinical stage of Parkinson’s disease (PD) (Knudsen et al, 2017; Chen et al, 2020)

  • These results suggested that 6-OHDA rats exhibited outlet obstruction constipation

  • This process involves oral contraction mediated by excitatory transmitters such as ACh and substance P (SP), and caudad relaxation mediated by inhibitory neurotransmitters such as vasoactive intestinal peptide (VIP), pituitary adenylate cyclaseassociated peptide (PACAP), and nitric oxide (Grider et al, 1998)

Read more

Summary

Introduction

Gastrointestinal (GI) symptoms, especially constipation and defecatory dysfunctions, are very common in the preclinical stage of Parkinson’s disease (PD) (Knudsen et al, 2017; Chen et al, 2020). Clinical diagnosis of PD is commonly dependent on cardinal motor symptoms (Tolosa et al, 2021), which occur when the loss of dopaminergic neurons reaches approximately 80% in the striatum and 40–50% or more in the substantia nigra (SN) (Fearnley and Lees, 1991; Johnson et al, 2018). Increasing evidence suggests that PD starts in the gut, with retrograde transmission of misfolded alpha-synuclein spreading from the enteric nervous system (ENS) to higher brain centers along vagal afferents (Braak et al, 2003; Holmqvist et al, 2014). This evidence may indicate that constipation in PD originates from dysfunction of the ENS. The pathogenesis by which dopaminergic neuron degeneration in the SN results in constipation remains unclear

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.